Thioridazine, successfully kills cancer stem cells in the human
- Details
- Category: Research
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.
Calcium supplements linked to significantly increased heart attack risk
- Details
- Category: Research
Calcium supplements might increase the risk of having a heart attack, and should be "taken with caution," concludes research published in the online issue of the journal Heart. Furthermore, boosting overall calcium intake from dietary sources confers no significant advantage in terms of staving off heart disease and stroke, the findings indicate.
Biomarker predicts response to cancer treatment
- Details
- Category: Research
VIB researcher Diether Lambrechts, associated with KU Leuven, has discovered a biomarker that might potentially predict which patients will benefit more from treatment with bevacizumab (Avastin). If validated, this discovery could be an important step towards personalized medicine and patient-tailored use of this important cancer drug.
In drug-approval race, US FDA ahead of Canada, Europe
- Details
- Category: Research
The U.S. Food and Drug Administration (FDA) generally approves drug therapies faster and earlier than its counterparts in Canada and Europe, according to a new study by Yale School of Medicine researchers. The study counters perceptions that the drug approval process in the United States is especially slow.
Blood pressure drugs don't protect against colorectal cancer
- Details
- Category: Research
A new study has found that, contrary to current thinking, taking beta blockers that treat high blood pressure does not decrease a person's risk of developing colorectal cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also revealed that even long-term use or subtypes of beta blockers showed no reduction of colorectal cancer risk.
Vitamin K2: New hope for Parkinson's patients?
- Details
- Category: Research
Neuroscientist Patrik Verstreken, associated with VIB and KU Leuven, succeeded in undoing the effect of one of the genetic defects that leads to Parkinson's using vitamin K2. His discovery gives hope to Parkinson's patients.
H1N1 discovery paves way for universal flu vaccine
- Details
- Category: Research
University of British Columbia researchers have found a potential way to develop universal flu vaccines and eliminate the need for seasonal flu vaccinations. Each year, seasonal influenza causes serious illnesses in three to five million people and 200,000 to 500,000 deaths.
More Pharma News ...
- Some HDL, or 'good' cholesterol, may not protect against heart disease
- Potential to revive abandoned cancer drug by nanoparticle drug delivery
- Stem cell researchers map new knowledge about insulin production
- New drug to tackle fat problems
- Key protein responsible for controlling nerve cell protection
- Women don't receive the same treatment as men for heart disease the world-over
- Advances in personalized medicine for lung cancer